Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 580406, 8 pages
http://dx.doi.org/10.1155/2015/580406
Review Article

Direct Cardiac Reprogramming: Advances in Cardiac Regeneration

Department of Pathology and Laboratory Medicine, McAllister Heart Institute, University of North Carolina, Chapel Hill, NC 27599, USA

Received 25 March 2015; Accepted 29 April 2015

Academic Editor: Shinsuke Yuasa

Copyright © 2015 Olivia Chen and Li Qian. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Executive summary: heart disease and stroke statistics—2015 update: a report from the American Heart Association,” Circulation, vol. 131, no. 4, pp. 434–441, 2015. View at Publisher · View at Google Scholar
  2. K. Kikuchi and K. D. Poss, “Cardiac regenerative capacity and mechanisms,” Annual Review of Cell and Developmental Biology, vol. 28, pp. 719–741, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Qian, Y. Huang, C. I. Spencer et al., “In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes,” Nature, vol. 485, no. 7400, pp. 593–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Ieda, J.-D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. T. M. Jayawardena, B. Egemnazarov, E. A. Finch et al., “MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes,” Circulation Research, vol. 110, no. 11, pp. 1465–1473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. Y.-J. Nam, K. Song, X. Luo et al., “Reprogramming of human fibroblasts toward a cardiac fate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5588–5593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. J.-D. Fu, N. R. Stone, L. Liu et al., “Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state,” Stem Cell Reports, vol. 1, no. 3, pp. 235–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Wada, N. Muraoka, K. Inagawa et al., “Induction of human cardiomyocyte-like cells from fibroblasts by defined factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 31, pp. 12667–12672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. B. Lassar, B. M. Paterson, and H. Weintraub, “Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts,” Cell, vol. 47, no. 5, pp. 649–656, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Weintraub, S. J. Tapscott, R. L. Davis et al., “Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 14, pp. 5434–5438, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Halder, P. Callaerts, and W. J. Gehring, “Induction of ectopic eyes by targeted expression of the eyeless gene in Drosophila,” Science, vol. 267, no. 5205, pp. 1788–1792, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. R. F. Santerre, K. R. Bales, M. J. Janney et al., “Expression of bovine myf5 induces ectopic skeletal muscle formation in transgenic mice,” Molecular and Cellular Biology, vol. 13, no. 10, pp. 6044–6051, 1993. View at Google Scholar · View at Scopus
  13. C. E. Murry, M. A. Kay, T. Bartosek, S. D. Hauschka, and S. M. Schwartz, “Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD,” Journal of Clinical Investigation, vol. 98, no. 10, pp. 2209–2217, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Gurdon, “The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles,” Journal of Embryology and Experimental Morphology, vol. 10, pp. 622–640, 1962. View at Google Scholar · View at Scopus
  15. K. Takahashi and S. Yamanaka, “Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,” Cell, vol. 126, no. 4, pp. 663–676, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Inoue, N. Nagata, H. Kurokawa, and S. Yamanaka, “IPS cells: a game changer for future medicine,” The EMBO Journal, vol. 33, no. 5, pp. 409–417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. W. Burridge, G. Keller, J. D. Gold, and J. C. Wu, “Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming,” Cell Stem Cell, vol. 10, no. 1, pp. 16–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Efe, S. Hilcove, J. Kim et al., “Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy,” Nature Cell Biology, vol. 13, no. 3, pp. 215–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Q. Zhou, J. Brown, A. Kanarek, J. Rajagopal, and D. A. Melton, “In vivo reprogramming of adult pancreatic exocrine cells to β-cells,” Nature, vol. 455, no. 7213, pp. 627–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Vierbuchen, A. Ostermeier, Z. P. Pang, Y. Kokubu, T. C. Südhof, and M. Wernig, “Direct conversion of fibroblasts to functional neurons by defined factors,” Nature, vol. 463, no. 7284, pp. 1035–1041, 2010. View at Google Scholar · View at Scopus
  21. P. Huang, Z. He, S. Ji et al., “Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors,” Nature, vol. 475, no. 7356, pp. 386–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Margariti, B. Winkler, E. Karamariti et al., “Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 34, pp. 13793–13798, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Szabo, S. Rampalli, R. M. Risueño et al., “Direct conversion of human fibroblasts to multilineage blood progenitors,” Nature, vol. 468, no. 7323, pp. 521–526, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Song, Y.-J. Nam, X. Luo et al., “Heart repair by reprogramming non-myocytes with cardiac transcription factors,” Nature, vol. 485, no. 7400, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Hirai, N. Katoku-Kikyo, S. A. Keirstead, and N. Kikyo, “Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain,” Cardiovascular Research, vol. 100, no. 1, pp. 105–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. Y.-J. Nam, C. Lubczyk, M. Bhakta et al., “Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors,” Development, vol. 141, no. 22, pp. 4267–4278, 2014. View at Publisher · View at Google Scholar
  27. S. Protze, S. Khattak, C. Poulet, D. Lindemann, E. M. Tanaka, and U. Ravens, “A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 3, pp. 323–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Christoforou, M. Chellappan, A. F. Adler et al., “Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming,” PLoS ONE, vol. 8, no. 5, Article ID e63577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. R. C. Addis, J. L. Ifkovits, F. Pinto et al., “Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success,” Journal of Molecular and Cellular Cardiology, vol. 60, no. 1, pp. 97–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. J. L. Ifkovits, R. C. Addis, J. A. Epstein, and J. D. Gearhart, “Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes,” PLoS ONE, vol. 9, no. 2, Article ID e89678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Muraoka, H. Yamakawa, K. Miyamoto et al., “MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures,” The EMBO Journal, vol. 33, no. 14, pp. 1565–1581, 2014. View at Publisher · View at Google Scholar
  32. J. K. Takeuchi and B. G. Bruneau, “Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors,” Nature, vol. 459, no. 7247, pp. 708–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Inagawa, K. Miyamoto, H. Yamakawa et al., “Induction of cardiomyocyte-like cells in infarct hearts by gene transfer of Gata4, Mef2c, and Tbx5,” Circulation Research, vol. 111, no. 9, pp. 1147–1156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Mathison, V. P. Singh, R. P. Gersch et al., “‘Triplet’ polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors,” The Journal of Thoracic and Cardiovascular Surgery, vol. 148, no. 4, pp. 1656–1664, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Mathison, R. P. Gersch, A. Nasser et al., “In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor,” Journal of the American Heart Association, vol. 1, no. 6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Srivastava, M. Ieda, J. Fu, and L. Qian, “Cardiac repair with thymosin β4 and cardiac reprogramming factors,” Annals of the New York Academy of Sciences, vol. 1270, no. 1, pp. 66–72, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. T. M. Jayawardena, E. A. Finch, L. Zhang et al., “MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function,” Circulation Research, vol. 116, no. 3, pp. 418–424, 2015. View at Publisher · View at Google Scholar
  38. P. Snider, K. N. Standley, J. Wang, M. Azhar, T. Doetschman, and S. J. Conway, “Origin of cardiac fibroblasts and the role of periostin,” Circulation Research, vol. 105, no. 10, pp. 934–947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. L. Wang, Z. Liu, C. Yin et al., “toichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming,” Circulation Research, vol. 116, no. 2, pp. 237–244, 2015. View at Publisher · View at Google Scholar
  40. J. X. Chen, M. Krane, M. A. Deutsch et al., “Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5,” Circulation Research, vol. 111, pp. 50–55, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. K. A. Gerbin and C. E. Murry, “The winding road to regenerating the human heart,” Cardiovascular Pathology, 2015. View at Publisher · View at Google Scholar